Ángeles Castro‐Iglesias

37th International Symposium on Intensive Care and Emergency Medicine (part 2 of 3)

Daniel Rob, R. Špunda, Jaroslav Lindner et al. · Critical Care · 2017 · 61 citations · Full text

Medicine, Emergency Medicine, Critical Care Medicine +7

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

Purificación Cid‐Silva, Noelia Fernández Bargiela, Luis Margusino‐Framiñán et al. · Basic & Clinical Pharmacology & Toxicology · 2018 · 48 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

Qian Chen, Celia Perales, María Eugenia Soria et al. · Antiviral Research · 2019 · 47 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in <scp>HIV</scp>‐infected Patients: Efficacy, Safety and Tolerance

Purificación Cid‐Silva, Josep M. Llibre, Noelia Fernández Bargiela et al. · Basic & Clinical Pharmacology & Toxicology · 2017 · 38 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?

Berta Pernas, Marta Grandal, Sónia Pértega-Díaz et al. · Journal of Antimicrobial Chemotherapy · 2015 · 31 citations · Full text

Life Sciences, Infectious Diseases, Molecular Virology +7